Epigenetic mechanisms in chronic obstructive pulmonary disease

被引:2
|
作者
Zong, D. -D. [1 ]
Ouyang, R. -Y. [1 ]
Chen, P. [1 ]
机构
[1] Cent S Univ, Xiangya Hosp 2, Dept Resp Med, Changsha, Hunan, Peoples R China
关键词
COPD; Epigenetics; DNA methylation; Histone methylation; Acetylation; Phosphorylation; Ubiquitination; NF-KAPPA-B; HISTONE DEACETYLASE ACTIVITY; INDUCED LUNG INFLAMMATION; CIGARETTE-SMOKE; OXIDATIVE STRESS; DNA METHYLATION; GENE-TRANSCRIPTION; CHROMATIN MODIFICATION; ABERRANT METHYLATION; ENDOTHELIAL-CELLS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Epigenetic modification may affect the expression of multiple inflammatory genes in lungs of patients with chronic obstructive pulmonary disease (COPD). Major epigenetic events include DNA methylation and various post-translational modifications of histones, such as histone methylation, acetylation, phosphorylation, ubiquitination, and sumoylation. Enzymes which regulate these epigenetic modifications can be activated by smoking. Both environmental and genetic factors play significant effect in development of COPD which have been reported by most references; however, little is known about the epigenetic pathways involved in the disease. Understanding the epigenetic mechanisms can help us clarify the pathogenesis of COPD and identify novel targets for developing new therapies for patients with COPD.
引用
收藏
页码:844 / 856
页数:13
相关论文
共 50 条
  • [41] Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease
    Rodrigues, Sarah de Oliveira
    Coeli da Cunha, Carolina Medina
    Valladao Soares, Giovanna Martins
    Silva, Pedro Leme
    Silva, Adriana Ribeiro
    Goncalves-de-Albuquerque, Cassiano Felippe
    PHARMACEUTICALS, 2021, 14 (10)
  • [42] MECHANISMS OF CHRONIC CARBON DIOXIDE RETENTION IN PATIENTS WITH OBSTRUCTIVE PULMONARY DISEASE
    GILBERT, R
    KEIGHLEY, J
    AUCHINCLOSS, JH
    AMERICAN JOURNAL OF MEDICINE, 1965, 38 (02): : 217 - +
  • [43] Weight loss in chronic obstructive pulmonary disease.: Mechanisms and implications
    Agustí, AGN
    Garí, PG
    Sauleda, J
    Busquets, X
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2002, 15 (05) : 425 - 432
  • [44] Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease
    Kayongo, Alex
    Nyiro, Brian
    Siddharthan, Trishul
    Kirenga, Bruce
    Checkley, William
    Joloba, Moses Lutaakome
    Ellner, Jerrold
    Salgame, Padmini
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [45] Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease
    Langen, R. C. J.
    Gosker, H. R.
    Remels, A. H. V.
    Schols, A. M. W. J.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2013, 45 (10): : 2245 - 2256
  • [46] Exertional dyspnea in chronic obstructive pulmonary disease: mechanisms and treatment approaches
    Ora, Josuel
    Jensen, Dennis
    O'Donnell, Denis E.
    CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (02) : 144 - 149
  • [47] Molecular Mechanisms of Inflammation During Exacerbations of Chronic Obstructive Pulmonary Disease
    Kersul, Ana L.
    Iglesias, Amanda
    Rios, Angel
    Noguera, Aina
    Forteza, Aina
    Serra, Enrique
    Agusti, Alvar
    Cosio, Borja G.
    ARCHIVOS DE BRONCONEUMOLOGIA, 2011, 47 (04): : 176 - 183
  • [48] Common Mechanisms Linking Chronic Obstructive Pulmonary Disease and Lung Cancer
    Houghton, A. McGarry
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 : S273 - S277
  • [49] Chronic obstructive pulmonary disease
    Peter J. Barnes
    Peter G. J. Burney
    Edwin K. Silverman
    Bartolome R. Celli
    Jørgen Vestbo
    Jadwiga A. Wedzicha
    Emiel F. M. Wouters
    Nature Reviews Disease Primers, 1
  • [50] Chronic Obstructive Pulmonary Disease
    Whittaker, Catherine
    SA PHARMACEUTICAL JOURNAL, 2010, 77 (07) : 32 - 36